DYN filings
Corporate insider profile
John Cox Filing Activity
Latest reported as CEO & President of Dyne Therapeutics, Inc. (DYN).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$109,969.35
- Latest transaction
- Jun 16, 2026
Affiliated corporations
Reported company relationships
Transaction history
